Many have been calling Exubera a bomb since it was introduced. Now the numbers back it up. I don’t know any primary care provider or endocrinologist who is prescribing this:
“Yesterday, Pfizer broke out Exubera sales for the first time, and now we know why it took this long: Exubera only sold $4 million in 2Q. This for a product that has been on the market for six quarters. We thought the number was missing a zero at first; we were at $63M for the quarter.”
